Although the development of two uncommon cancers is not direct evidence that DNMT3A haploinsufficiency generates a premalignant state for skin tumors, preclinical models have suggested that Dnmt3a deficiency causes proliferative priming as a potential mechanism (Rinaldi et al. 2017; Chen et al. 2021). This evidence concerns the gene DNMT3A and cancer.